C12N2710/24011 - CPC Classification

dsDNA viruses; Details Poxviridae

• C12N2710/24021 » Viruses as such, e.g. new isolates, mutants or their genomic sequences 19
• C12N2710/24022 » New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes 27
• C12N2710/24023 » Virus like particles [VLP] 2
• C12N2710/24031 » Uses of virus other than therapeutic or vaccine, e.g. disinfectant 1
• C12N2710/24032 » Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent 30
• C12N2710/24033 » Use of viral protein as therapeutic agent other than vaccine, e.g. apoptosis inducing or anti-inflammatory 8
• C12N2710/24034 » Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein 50
• C12N2710/24041 » Use of virus, viral particle or viral elements as a vector 16
• C12N2710/24051 » Methods of production or purification of viral material 5
• C12N2710/24061 » Methods of inactivation or attenuation 1
• C12N2710/24071 » Demonstrated in vivo effect 26
• C12N2710/24088 » For redistribution 0
• C12N2710/24111 » Orthopoxvirus, e.g. vaccinia virus, variola 17
• C12N2710/24211 » Parapoxvirus, e.g. Orf virus 0

Recent Application in this class: